Company intelligence / Profile preview

OrganoidSciences

Seongnam-si, Gyeonggi-do, South Koreaorganoidrx.com ↗

Ownership: Private
Employees: ~86
Development stage: Other

Overview

Organoid Sciences is a South Korean biotechnology company specializing in 3D organoid technology for regenerative medicine and drug discovery. The company's proprietary ATORM platform develops adult tissue-derived organoid therapeutics designed to directly regenerate damaged tissues, with its lead candidate ATORM-C currently in Phase 1 clinical trials for Crohn's disease and Behcet's enteritis. Additionally, Organoid Sciences commercializes ODISEI, an advanced organoid-based drug evaluation platform that replicates human-like microenvironments to assess drug efficacy and toxicity, serving as an ethical alternative to animal testing. Founded in 2018, the company is listed on the KOSDAQ exchange and operates GMP-certified manufacturing facilities to support its clinical and commercial pipelines.

Therapeutic areas: GastroenterologyOtherWomen's Health
Modalities: Cell therapyStem cell therapyBiologic
Industry: Biotech

Drug pipeline

2 assets

ATORM-E

Preclinical

1 more asset in the full pipeline.

Partnerships

Lambda BiologicsKorea Research Institute of Bioscience and Biotechnology (KRIBB)Dongwha Pharm

Beyond the preview

Go deeper on OrganoidSciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OrganoidSciences.